These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3935372)

  • 41. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
    Croxatto HB; Díaz S; Pavez M; Brandeis A
    Contraception; 1988 Oct; 38(4):465-75. PubMed ID: 3145171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endometrial angiogenic response in Norplant users.
    Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Norplant contraceptive subdermal implants: one year experience in Singapore.
    Singh K; Viegas OA; Ratnam SS
    Contraception; 1988 May; 37(5):457-69. PubMed ID: 3136971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
    Croxatto HB; Diaz S; Pavez M; Miranda P; Brandeis A
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levonorgestrel concentrations in maternal and infant serum during use of subdermal levonorgestrel contraceptive implants, Norplant, by nursing mothers.
    Shaaban MM; Odlind V; Salem HT; Abdullah KA; Gomaa AA
    Contraception; 1986 Apr; 33(4):357-63. PubMed ID: 3089681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Norplant contraceptive implants--a comparison of capsules versus rods in Singapore.
    Singh K; Viegas OA; Ratnam SS
    Singapore Med J; 1990 Dec; 31(6):568-72. PubMed ID: 2126394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Norplant-2 rods: one year experience in Singapore.
    Singh K; Viegas OA; Liew D; Singh P; Ratnam SS
    Contraception; 1988 Oct; 38(4):429-40. PubMed ID: 3145168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contraception with long-acting subdermal implants. A five-year clinical trial with Silastic covered rod implants containing levonorgestrel. The International Committee for Contraception Research (ICCR) of the Population Council.
    Robertson DN; Diaz S; Alvarez-Sanchez F; Holma P; Mishell DR; Coutinho E; Brache V; Croxatto HB; Faundes A; Lacarra M
    Contraception; 1985 Apr; 31(4):351-9. PubMed ID: 3924476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subjective perception of bleeding and serum ferritin concentration in long-term users of Norplant.
    Faundes A; Tejada AS; Brache V; Alvarez F
    Contraception; 1987 Feb; 35(2):189-96. PubMed ID: 3109804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pregnancy after removal of Norplant implants contraceptive.
    Affandi B; Santoso SS; Djajadilaga ; Hadisaputra W; Moeloek FA; Prihartono J; Lubis F; Samil RS
    Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma levels of levonorgestrel in women during longterm use of Norplants.
    Croxatto HB; Díaz S; Miranda P; Elamsson K; Johansson ED
    Contraception; 1980 Dec; 22(6):583-96. PubMed ID: 6971208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of Norplant on clinical chemistry in Singaporean acceptors after 1 year of use: metabolic changes.
    Viegas OA; Singh K; Liew D; Singh P; Ratnam SS
    Contraception; 1988 Jul; 38(1):79-89. PubMed ID: 3139359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants.
    Odlind V; Olsson SE
    Contraception; 1986 Mar; 33(3):257-61. PubMed ID: 3087695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
    Alvarez F; Brache V; Tejada AS; Faúndes A
    Contraception; 1986 Feb; 33(2):111-9. PubMed ID: 3084166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.